Patient Characteristics Associated With Chemotherapy-Induced Peripheral Neuropathy Severity in a Phase II Clinical Trial: A Retrospective Analysis is a research paper published in The Oncologist (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R37CA248563-01A1
Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT)Trial
National Cancer Institute
Grant: P30 CA008748
NCI NIH HHS
Grant: R37 CA248563
National Institutes of Health
Grant: 5R01CA251470-02
Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
Memorial Sloan-Kettering Cancer Center
FWCI
1.52
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals